United States - English - NLM (National Library of Medicine)

akorn - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

United States - English - NLM (National Library of Medicine)

emd serono, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix 0.25 mg in 1 ml - cetrotide® (cetrorelix acetate for injection) is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrotide® (cetrorelix acetate for injection) is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - cetrorelix (as cetrorelix acetate) - injection - 0.25 mg - cetrorelix (as cetrorelix acetate) 0.25 mg

Canada - English - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 0.25mg - cetrorelix (cetrorelix acetate) 0.25mg - gonadotropin-releasing hormone antagonists

Canada - English - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 3mg - cetrorelix (cetrorelix acetate) 3mg - gonadotropin-releasing hormone antagonists

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - cetrorelix, quantity: 0.25 mg - injection, powder for - excipient ingredients: mannitol - indications: prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques. in clinical trials cetrotide was used with human menopausal gonadotrophin (hmg), however limited experience with recombinant fsh suggested similar efficacy.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bsv bioscience malaysia sdn. bhd. - cetrorelix -

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - cetrorelix (as acetate) - ovulation; ovulation induction - pituitary and hypothalamic hormones and analogues - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte-pick-up and assisted-reproductive techniques.in clinical trials, cetrotide was used with human menopausal gonadotropin (hmg), however, limited experience with recombinant follicule-stimulating hormone (fsh) suggested similar efficacy.

Israel - English - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.